Parenteral Drugs (India) Limited(IN:PDPL)
$2.900.00 (0.00%)
IN:PDPL
Parenteral Drugs (India) Limited financials statements
$2.90
At close:0.00 (0.00%)
Parenteral Drugs (India) Limited (PDPL) Income Statement
0 Followers
Parenteral Drugs (India) Limited Income Statement
Last quarter (Q4 2022), Parenteral Drugs (India) Limited's total revenue was ₹17.73M, an increase of 143.66% from the same quarter last year. In Q4, Parenteral Drugs (India) Limited's net income was ₹238.13M. See Parenteral Drugs (India) Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| ₹ 84.96M | ₹ 121.53M | ₹ 240.25M | ₹ 319.98M | ₹ 2.17B | |
| ₹ 30.31M | ₹ 48.37M | ₹ 13.40M | ₹ 75.64M | ₹ 370.93M | |
| ₹ 147.87M | ₹ 356.03M | ₹ 329.28M | ₹ 943.42M | ₹ 796.06M | |
| Depreciation and Amortization | ₹ 401.48M | ₹ 173.26M | ₹ 173.46M | ₹ 691.19M | ₹ 242.43M |
| ₹ 372.69M | ₹ -117.09M | ₹ -144.39M | ₹ -162.40M | ₹ -12.93M | |
| ₹ -117.56K | ₹ -82.97K | ₹ -320.32K | ₹ -867.78K | ₹ -425.13M | |
| ₹ -973.70K | ₹ -1.46M | ₹ -1.42B | ₹ -946.19M | ₹ -987.37M | |
| ₹ -1.09M | ₹ -1.54M | ₹ -1.42B | ₹ -1.81B | ₹ -1.41B | |
| ₹ -763.62M | ₹ -1.22B | ₹ -1.14B | ₹ -1.48B | ₹ -1.19B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ -25.61 | ₹ -40.82 | ₹ -38.26 | ₹ -49.61 | ₹ -39.89 |
| Diluted EPS | ₹ -25.61 | ₹ -40.82 | ₹ -38.26 | ₹ -49.61 | ₹ -39.89 |
| Weighted Average Shares Outstanding | 29.82M | 29.82M | 29.82M | 29.82M | 29.82M |
| Weighted Average Shares Outstanding (Diluted) | 29.82M | 29.82M | 29.82M | 29.82M | 29.82M |
Currency in INR
